Jan Gummert, MD, PhD

Transfemoral Aortic Valve-in-Valve Implantation With the CoreValve Evolut for Small Degenerated Stented Bioprosthesis

06/02/2014

Jan Gummert , MD, PhD;

Dieter Horstkotte , MD, PhD;

Werner Scholtz , MD;

Jochen Börgermann , MD, PhD;

Smita R. Jategaonkar , MD;

Stephan M. Ensminger , MD, PhD;

Transcatheter aortic valve-in-valve implantation represents one interesting therapeutic option for high-risk surgical patients with degenerated bioprostheses. We report our initial experience with the 23 mm CoreValve Evolut in 4 patients with...

Transcatheter aortic...

06/02/2014

Journal of Invasive Cardiology

Transcatheter Aortic Valve Implantation in Patients With Pre-Existing Mechanical Mitral Valve Prostheses

08/27/2019

Smita Scholtz , MD;

Cornelia Piper , MD, PhD;

Dieter Horstkotte , MD, PhD;

Nobuyuki Furukawa , MD;

Jochen Börgermann , MD, PhD;

Tanja K. Rudolph , MD, PhD;

Volker Rudolph , MD, PhD;

Werner Scholtz , MD;

Jan Gummert , MD, PhD;

Treatment of TAVI patients with pre-existing mechanical mitral valve replacement is challenging due to possible interference between the TAVI prosthesis and the mechanical valve. We present our single-center experience with 16 patients in...

Treatment of TAVI patients with...

08/27/2019

Journal of Invasive Cardiology

Original Contribution

A Novel Model to Predict 1-Year Mortality in Elective Transfemoral Aortic Valve Replacement: The TAVR-Risk Score

10/13/2022

Georg Wolff , MD;

Raphael Romano Bruno , MD;

Tobias Zeus , MD;

Artur Lichtenberg ;

Malte Kelm , MD;

Friedhelm Beyersdorf ;

Christian Jung , MD, PhD;

Christian W. Hamm , MD, PhD, FESC;

Jan Gummert , MD, PhD;

Andreas M. Zeiher , MD;

Magnus Settergren , MD;

Amin Polzin , MD;

Bernhard Wernly , MD, PhD;

Christian Frerker , MD;

Raffi Bekeredjian , MD;

Timm Bauer , MD;

Andreas Beckmann , MD;

Sabine Bleiziffer , MD;

Stephan M. Ensminger , MD, PhD;

Helge Möllmann , MD, PhD;

Christopher U. Meduri , MD, MPH;

Thomas Walther , MD, PhD;

Kari Feldt , MD;

We aimed to develop and validate an effective prediction model for 1-year mortality risk in elective transfemoral transcatheter aortic valve replacement (TAVR), ie, the TAVR-Risk (TARI) model.

We aimed to develop and validate...

10/13/2022

Journal of Invasive Cardiology